53
Views
9
CrossRef citations to date
0
Altmetric
Expert Opinion

The role of ziprasidone in adjunctive use with lithium or valproate in maintenance treatment of bipolar disorder

Pages 87-92 | Published online: 07 Mar 2011

References

  • VietaESuppesTEggensIPerssonIPaulssonBBrecherMEfficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126)J Affect Disord200810925126318579216
  • SuppesTVietaELiuSBrecherMPaulssonBMaintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (trial 127)Am J Psychiatry200916647619289454
  • BowdenCLVietaEIceKSSchwartzJHWangPPVersavelMZiprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month randomized, placebo-controlled, double-blind trialJ Clin Psychiatry20107113013720122373
  • TohenMCalabreseJRSachsGSRandomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapineAm J Psychiatry200616324725616449478
  • WolfspergerMGreilWRösslerWGrohmannRPharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004J Affect Disord20079991716989907
  • FreemanMPStollALMood stabilizer combinations: a review of safety and efficacyAm J Psychiatry1998155129433333
  • LevineJChengappaKNRBrarJSGershonSYablonskyEStapfDPsychotropic drug prescription patterns among patients with bipolar I disorderBipolar Disord2000212013011252651
  • SuppesTDennehyEBHirschfeldRMAAltshulerLLBowdenCLCalabreseJRThe Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorderJ Clin Psychiatry20056687088616013903
  • YathamLNKennedySHSchafferAParikhSVBeaulieuSO’DonovanCCanadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009Bipolar Disord20091122525519419382
  • GrunzeHVietaEGoodwinGMBowdenCLichtRWMöllerHJThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute maniaWorld J Biol Psychiatry2009108511619347775
  • KeckPEJrVersianiMPotkinSWestSAGillerEIceKZiprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trialAm J Psychiatry200316074174812668364
  • VietaERameyTKellerDEnglishPALoebelADMiceliJZiprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced studyJ Psychopharmacol20102454755819074536
  • TohenMVietaEGoodwinGMOlanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind studyJ Clinical Psychiatry2008691776178919014751
  • Van der LoosMLMulderPGHartongEGLamLit Study GroupEfficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trialJ Clin Psychiatry20097022323119200421
  • CalabreseJRBowdenCLSachsGA placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorderJ Clin Psychiatry2003641013102414628976
  • BowdenCLCalabreseJRSachsGA placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorderArch Gen Psychiatry20036039240012695317
  • BowdenCLCalabreseJRMcElroySLA randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorderArch Gen Psychiatry20005748148910807488
  • GueorguievaRKrystalJHMove over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General PsychiatryArch Gen Psychiatry20046131031714993119
  • HedekerDGibbonsRDLongitudinal Data Analysis1st edWiley-Interscience2006